Pediatric Prospective Personalized Immune and Target Identification Trial

NCT04859543 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Neoplasms
Pediatric Cancer
GEN1 Gene Mutation
Tumor, Brain

Interventions

DEVICE: FoundationOneHeme

Sponsor

Masaryk University

Collaborators

[object Object]
[object Object]